Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 33
(15_suppl)
◽
pp. e19084-e19084
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2021 ◽
pp. 1-13
Keyword(s):